Intensity Therapeutics (INTS) Return on Capital Employed [ROCE] (2023 - 2026)
Intensity Therapeutics' Return on Capital Employed [ROCE] was -118.86% in Q2 2026, up 690.70 percentage points from -809.56% a year earlier but down 17.49 percentage points from the prior quarter.
Powered by 
Analysis
Intensity Therapeutics (INTS) Return on Capital Employed [ROCE] (2023 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Intensity Therapeutics came in at -164.09%, up 14.55 percentage points from FY2024.
- In earlier years, Return on Capital Employed [ROCE] was -178.64% in FY2024 (-29.21 pp) and -149.43% in FY2023.
- Quarterly Return on Capital Employed [ROCE] has moved between -1176.53% (Q1 2025) and -38.34% (Q3 2023) over five years.
- Compared with a year earlier, Return on Capital Employed [ROCE] has increased for four straight quarters, with an average year-over-year change of -23.34 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2026 (a gain of 1075.16 percentage points); the worst was Q1 2025 (a drop of 1080.79 percentage points).
- Per Business Quant data, INTS's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -101.37% (Q1 2026), -123.46% (Q4 2025) and -254.01% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 17.83% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 17.92% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.28% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 19.32% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.54% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 16.66% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -5.97% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 11.86% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.76% |
| 10 | Intensity Therapeutics | 9.93 Mn | 9.93 Mn | - | -118.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -118.86% |
| Mar 31, 2026 | -101.37% |
| Dec 31, 2025 | -123.46% |
| Sep 30, 2025 | -254.01% |
| Jun 30, 2025 | -809.56% |
| Mar 31, 2025 | -1,176.53% |
| Dec 31, 2024 | -511.41% |
| Sep 30, 2024 | -361.74% |
| Jun 30, 2024 | -213.39% |
| Mar 31, 2024 | -95.74% |
| Dec 31, 2023 | -63.51% |
| Sep 30, 2023 | -38.34% |
API Access
Intensity Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "INTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=INTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();